Atlas Trials

High-risk Large B-cell Lymphoma (LBCL)

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High-risk Large B-cell Lymphoma (LBCL)

RecordFirmDate
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma (NCT06935136)Ruijin Hospital2025-04-30
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma (NCT05605899)Kite, A Gilead Company2023-02-10

Track High-risk Large B-cell Lymphoma (LBCL) automatically

Every clearance here is in the API, with alerts when new ones post.